Just six months after taking Labour to power, the Prime Minister now faces an uprising from Party members enraged by broken ...

A deeper analysis reveals systemic challenges, including the quality and independence of parliamentarians, that limit the ...

A judge ruled on Thursday that Milwaukee Public Schools (MPS) must place 25 School Resource Officers (SROs) at public schools across the ...

Central NC rarely gets snow during winter, so I took the opportunity to fly my drone at one of my favorite spots near downtown. I wanted the video to be a minute long with no audio to simply enjoy the ...

Speaking to media this morning from his party caucus retreat, Luxon said it was wonderful to have the National team and some ...

DNLI has had a good run in the past year on positive pipeline updates. A potential approval of its Hunter Syndrome drug should be a boost. However, recent pipeline setbacks warrant caution.

Regenxbio's rolling BLA submission completion of RGX-121 for the treatment of patients with MPS II expected in Q1 of 2025.

Undervalued biotech company Regenxbio Inc. shows promise with cutting-edge gene therapy technology for AMD and MPS II. Click ...

The partnership between REGENXBIO and Nippon Shinyaku is more than just a standard collaboration—it’s a bold, forward-looking venture aimed at bringing revolutionary gene therapies to market for rare, ...

Regenxbio (RGNX) and Nippon Shinyaku announced a strategic partnership for the development and commercialization of RGX-121 for the treatment ...

FHA loans are invaluable for countless first-time home buyers. Despite the perks, though, FHA loans do come with some strict rules when it comes to appraisals.

In 2021, the U.S. Food and Drug Administration granted Fast Track designation to tividenofusp alfa for the treatment of patients with Hunter syndrome (MPS II). In 2022, the European Medicines Agency ...